MedTrace Logo

IOTA Ultrasound Criteria and Serum CA 125 for Ovarian Malignancy Detection

NCT06977334 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 64

Last updated 2025-05-18

No results posted yet for this study

Summary

This cross-sectional analytic study assessed the diagnostic accuracy of IOTA Simple Rules versus serum CA 125 in women with adnexal masses undergoing surgery. Eighty-two percent of tumors were classifiable by IOTA criteria; CA 125 cut-offs of 35, 70, and 105 U/mL were evaluated against histopathology gold standard.

Conditions

Sponsors & Collaborators

  • Maharajgunj Medical Campus

    lead OTHER

Principal Investigators

  • Chandrika Dangol, MD · Nobel Medical College Teaching Hospital

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Nepal

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06977334 on ClinicalTrials.gov